Network boosts UK radiotherapy research
A new network to modernise long-term radiotherapy research in the UK has been launched.
The Academic Clinical Oncology and Radiobiology Research Network (ACORRN), a National Cancer Research Institute (NCRI) initiative, aims to develop a first-rate co-ordinated network of researchers to foster fundamental research opportunities. ACORRN is jointly funded by Cancer Research UK, the Medical Research Council and the Department of Health, and is anticipated to bring a host of benefits to cancer patients.
The network will raise the profile and help support independent radiotherapy research in the UK whilst attracting long-term funding. It is also hoped to develop improved training opportunities for professionals to remain in radiotherapy research.
Professor Pat Price, Chair of ACORRN said: 'Over the last 10 years, radiotherapy has seen one of the most rapid advances in technology and computerisation in any field of medicine. This, combined with advances in cell and molecular biology, means that now radiotherapy research has the potential to be one of the most dynamic and clinically relevant fields.'
She adds: 'For the first time, researchers can all work together to exploit this great potential.'
ACORRN will encourage networking and research collaboration through an interactive website whilst providing advice and assistance on funding, grant applications, ethics legislation and approval. Radiographers will be encouraged to get involved. The network will work in collaboration with the UK research community to re-establish a strong radiotherapy base.
Click here to visit the ACORRN website.
Back | Top
|
